CD274 and neoplasm: Upregulation of PD-L1 is observed in 14–29% of Wilms tumors [117,118], and it is correlated with poor prognosis in aggressive subtypes, with a higher risk of recurrence in the case of favorable histology, independent of tumor stage [119].